CIK 0001520262 · Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981007018
- Phone
- 00-353-1-772-8000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- 4 Shares withheld for taxes VP, Finance (Interim PAO) gave up 1,685 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief Commercial Officer gave up 4,146 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Operating Officer gave up 7,926 shares (to pay taxes)
- 4 Shares withheld for taxes EVP R&D, Chief Medical Officer gave up 6,911 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, CLO, Alkermes, Inc. gave up 5,533 shares (to pay taxes)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Material agreement · Agreement ended · Acquisition or sale completed · New debt or obligation · Regulation FD disclosure
- 4 Shares withheld for taxes Director and CEO, Alkermes plc gave up 62,230 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief Commercial Officer gave up 6,389 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Operating Officer gave up 8,626 shares (to pay taxes)
- 4 Shares withheld for taxes EVP R&D, Chief Medical Officer gave up 7,454 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, CLO, Alkermes, Inc. gave up 7,619 shares (to pay taxes)
- 4 Planned sale EVP R&D, Chief Medical Officer sold 9,000 shares at an average $33.93 ($305,385)
- 4 Planned sale Director sold 61,200 shares at an average $34.57 ($2,115,673)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Results of operations · Regulation FD disclosure
- 144 Insider Sale of Securities
- 4 Planned sale EVP R&D, Chief Medical Officer sold 5,000 shares at $30.00 ($150,005)
- 8-K Event Regulation FD disclosure · Other events
Page 6 of 97 · 1,927 filings